Compare Amphastar Pharmaceuticals Inc (AMPH) vs Alphabet Inc Class A (GOOGL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Alphabet (GOOGL) trades at $357.18, down 0.48% on the day, with a neutral technical signal despite bullish moving averages. The company demonstrates strong fundamental performance with consecutive earnings beats, robust revenue growth to $402.84B in 2025, and expanding profit margins. Recent news highlights AI-driven growth opportunities through partnerships with Anthropic and Intel, while YouTube's subscription price increase signals pricing power. The stock trades below the analyst consensus price target of $432.22, representing approximately 21% upside potential.

The outlook remains positive given strong earnings momentum, AI infrastructure leadership, and diversified revenue streams. Key risks include antitrust scrutiny, competitive pressures in AI and cloud computing, and market rotation out of tech stocks. With 85% analyst buy ratings and institutional positioning adjustments, the stock presents a growth opportunity tempered by regulatory and execution risks.